Fondo Bibliografico Internacional Mayo 2002
Cirrosis hepática
Muretto P, Angelucci E and Lucarelli G. Reversibility
of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation.
Annals of Internal Medicine 2002; 136: 667-72.
Caso clínico.
Hirata M, Harihara Y, Kita Y, et al. Immunosuppressive
Effect of Chenodeoxycholic Acid on Natural Killer Cell Activity in Patients
with Biliary Atresia and Hepatitis C Virus-Related Liver Cirrhosis. Digestive
Diseases and Science 2002; 47: 1100-6.
Efecto inmunosupresor del ácido quenodesoxicólico en pacientes
con cirrosis hepática o atresia biliar.
Trevisani F, Castelli E, Foschi FG, et al. Impaired
tuftsin activity in cirrhosis: relationship with splenic function and clinical
outcome. Gut 2002; 50: 707-12.
La actividad tuftsina está reducida en la cirrosis hepática
y contribuye a la disfunción del sistema reticuloendotelial.
